norgestrel has been researched along with desogestrel in 134 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 51 (38.06) | 18.7374 |
| 1990's | 50 (37.31) | 18.2507 |
| 2000's | 18 (13.43) | 29.6817 |
| 2010's | 14 (10.45) | 24.3611 |
| 2020's | 1 (0.75) | 2.80 |
| Authors | Studies |
|---|---|
| Corson, SL; Kafrissen, ME | 1 |
| London, RS | 1 |
| Chen, JK; Fan, BC; Fotherby, K; He, ML; Li, LM; Rekers, H; Song, S; Yang, PJ | 1 |
| Anderson, DC; Buckler, HM; Burger, HG; Evans, CA; Mamtora, H | 1 |
| Atsma, WJ; Fioretti, P; Fruzzetti, F; Lammers, P; Melis, GB; Nicoletti, I; Ricci, C | 1 |
| Berger, GM; Maritz, JS; Sapire, KE | 1 |
| Christiansen, C; Haarbo, J; Hassager, C; Jensen, SB; Riis, BJ | 1 |
| Csemiczky, G; Landgren, BM | 1 |
| Rebar, RW; Zeserson, K | 1 |
| Babor, P; Feichtinger, W; Herczeg, KM; Heyda, M; Hoffmann, R; Plöckinger, B; Steinhauser, B | 1 |
| Laine, M; Ojanotko-Harri, A; Pienihäkkinen, K; Tenovuo, J | 1 |
| Ho, PC; Kwan, MS; Liu, WT | 1 |
| Johansson, E; Odlind, V; Olsson, SE | 1 |
| Hahn, DW; McGuire, JL; Phillips, A | 1 |
| Fotherby, K | 1 |
| Kloosterboer, HJ; Rekers, H | 1 |
| David, JL; Gaspard, UJ; Gillain, D; Lepot, MR; Raskinet, R | 1 |
| Roy, S; Stanczyk, FZ | 1 |
| Anyaoku, V; Crook, D; Devenport, M; Felton, C; Godsland, IF; Lees, B; Proudler, T; Simpson, R; Wynn, V | 1 |
| Bauer, K; Jürgensen, R; Kaffarnik, H; Steinmetz, A | 1 |
| Assendorp, R; Bergink, W; Kloosterboer, L; Qvist, I; van Lier, W; Voortman, G | 1 |
| Back, DJ; Madden, S; Orme, ML | 1 |
| Jung-Hoffman, C; Kuhl, H | 1 |
| Bilotta, P; Calabresi, L; Franceschini, G; Gianfranceschi, G; Sirtori, CR; Winkler, S; Zampetti, A; Zoppi, F | 1 |
| Edén, S; Karlsson, R; von Schoultz, B | 1 |
| Juchem, M; Pollow, K | 1 |
| Kivinén, S; Palatsi, R; Reinilä, M | 1 |
| Liew, D; Prasad, RN; Ratnam, SS | 1 |
| Chez, RA | 2 |
| Koh, S; Prasad, RN; Ratnam, SS | 1 |
| Nilsson, B; von Schoultz, B | 1 |
| Haspels, AA; Kloosterboer, HJ; van der Berg, H; van der Vange, N | 1 |
| Elstein, M; Eyong, E; Killick, SR; Priddy, AR | 1 |
| Bonnar, J; Carroll, E; Daly, L | 1 |
| Gahn, G; Kuhl, H; März, W; Romberg, G; Taubert, HD | 1 |
| Gahn, G; Gross, W; Kuhl, H; März, W; Romberg, G; Taubert, HD | 1 |
| Althoff, PH; Gahn, G; Kuhl, H; Romberg, G; Taubert, HD | 1 |
| Ide, P; Wynants, P | 1 |
| De Meyts, P; Gaspard, UJ; Grigorescu, F; Lefèbvre, PJ; Luyckx, AS; Romus, MA | 1 |
| Bonnar, J; Sabra, AM | 1 |
| Mall-Haefeli, M | 1 |
| Kloosterboer, HJ; van den Ende, A; van Wayjen, RG | 1 |
| Jung-Hoffmann, C; Kuhl, H | 1 |
| Doornebos, CM; Hamerlynck, JV; Muntendam, P; Vollebregt, JA | 1 |
| Hoppe, G | 1 |
| Bonnar, J | 1 |
| Rabe, T; Runnebaum, B | 1 |
| Kuusi, T; Tikkanen, MJ; Viinikka, L; Ylikorkala, O | 1 |
| Balestreri, R; Bertolini, S; Cordera, R; Croce, S; De Cecco, L; Elicio, N; Gapitanio, GL; Montagna, G; Saturnino, M | 1 |
| Erkkola, R; Grönroos, M; Järnström, S; Liukko, P; Näntö, V; Pakarinen, P | 1 |
| Bergink, EW; Erkkola, R; Liukko, P | 1 |
| Desager, JP; Gaspard, U; Harvengt, C; Lepot, M | 1 |
| Göretzlehner, G; Köhler, G | 1 |
| Chailurkit, L; Phiromsawat, S; Rojanasakul, A; Sirimongkolkasem, R | 1 |
| Benraad, TJ; Meulenberg, PM; Ross, HA; Swinkels, LM | 1 |
| Anderson, DC; Evans, A; Mamtora, H; Mavroudis, K; Robertson, WR | 1 |
| Kloosterboer, HJ; Turpijn, EW; Vonk-Noordegraaf, CA | 1 |
| Demeter, J; Gáti, I; Gerö, G; Rákóczi, I | 1 |
| Kuusi, T; Nikkilä, EA; Sipinen, S; Tikkanen, MJ | 2 |
| Buret, J; Gaspard, UJ; Gillain, D; Lambotte, R; Romus, MA | 1 |
| Dallenbach-Hellweg, G; Fenzel, J | 1 |
| Crona, N; Samsioe, G; Silfverstolpe, G | 2 |
| Käär, K; Ruokonen, A | 1 |
| Kuhl, H; Mehlis, W; Sandow, J; Taubert, HD; Weber, W | 1 |
| Bergink, EW; Borglin, NE; Klottrup, P; Liukko, P | 1 |
| Samsioe, G | 1 |
| Baumgarten, S; Hammerstein, J; Römmler, A; Schwartz, U | 1 |
| Alapiessa, U; Lund, L; Nummi, S; Ruokonen, A; Viinikka, L | 1 |
| Andersen, NB; Andersen, RF; Bredesgaard, P; Cullberg, G; Ernerot, H; Fanøe, E; Fylling, P; Haack-Sørensen, PE; Klottrup, P; Pedersen, JH; Samsioe, G; Sandager, T | 1 |
| de Visser, J; van der Vies, J | 1 |
| Demey-Ponsart, E; Duvivier, J; Franchimont, P; Gaspard, UJ; Gillain, D; Romus, MA | 1 |
| Hammond, GL; Langley, MS; Lund, L; Nummi, S; Robinson, PA | 1 |
| Bergink, EW; Kloosterboer, HJ; Lund, L; Nummi, S | 1 |
| Crona, N; Enk, L; Samsioe, G; Silfverstolpe, G | 1 |
| Hau, J; Nielsen, CH; Poulsen, HK; Teisner, B; Thorsen, P; Westergaard, JG | 1 |
| Egarter, C; Huber, J; Putz, M; Speiser, P; Strohmer, H; Wenzl, R | 1 |
| Gudkova, MA; Krymskaia, ML; Kulakov, VI; Solov'eva, AD | 1 |
| Sobel, NB | 1 |
| Janosz, P; Jendryczko, A; Tomala, J | 1 |
| DeCherney, A; Speroff, L | 1 |
| Back, DJ; Rudland, PS; Wild, MJ | 1 |
| Creatsas, G; Serfaty, D; Verougstraete, A; Wildemeersch, D | 1 |
| Borm, GF; Coenen, CM; Rolland, R; Thomas, CM | 1 |
| Teichmann, A | 1 |
| Amiral, J; Guize, L; Plu-Bureau, G; Scarabin, PY | 1 |
| Borm, GF; Coenen, CM; Hollanders, JM; Rolland, R; Thomas, CM | 1 |
| Creinin, MD | 1 |
| Bruppacher, R; Heinemann, LA; Lewis, MA; MacRae, KD; Spitzer, WO | 1 |
| Lidegaard, O | 1 |
| Schwingl, PJ; Shelton, J | 1 |
| Bloemenkamp, KW; Helmerhorst, FM; Rosendaal, FR; Vandenbroucke, JP | 1 |
| Hamulyak, K; Heijnen, P; Hemker, HC; Nicolaes, GA; Rosing, J; Tans, G; Thomassen, MC; van der Ploeg, PM; van Oerle, R | 1 |
| Stanczyk, FZ | 1 |
| Nitsche, DC; Rabe, T; Runnebaum, B | 1 |
| Meyers, A; Rosenberg, MJ; Roy, V | 1 |
| Malinova, M; Pekhlivanov, B; Sirakova, I; Ulichkova, E | 1 |
| Cusson, J; Heinemann, L; Lewis, M; Rainville, B; Spitzer, WO; Suissa, S | 1 |
| Bak, AA; Bennink, HJ; Bots, ML; Grobbee, DE; Ossewaarde, ME; Planellas, J; Van Der Schouw, YT; Witteman, JC | 1 |
| Bak, AA; Coelingh Bennink, HJ; Grobbee, DE; Hak, AE; Hofman, A; Lindemans, J; Planellas, J; Witteman, JC | 1 |
| Milsom, I; Odlind, V; Persson, I; Victor, A | 1 |
| Auerbach, L; Hafner, T; Huber, JC; Panzer, S | 1 |
| Hussar, D | 1 |
| Evans, SL; Forinash, AB | 1 |
| Kaunitz, AM | 1 |
| del Marmol, V; Gertsen, K; Teichmann, A | 1 |
| Baerwald, AR; Olatunbosun, OA; Pierson, RA | 1 |
| Levine, JP | 1 |
| O'Connell, KJ; Osborne, LM; Westhoff, C | 1 |
| Radowicki, S; Skórzewska, K; Szlendak, K | 1 |
| Szarewski, A | 1 |
| Jick, H; Jick, SS; Kaye, JA; Russmann, S | 1 |
| Jick, H; Jick, SS | 1 |
| Atlas, M; Gordon, L; Januchowski, R; Thakur, N | 1 |
| Burkman, RT; Fisher, AC; LaGuardia, KD | 1 |
| Abbiati, A; Barbara, G; Bianchi, S; Fedele, L; Somigliana, E; Vercellini, P | 1 |
| Buono, MJ; Martin, JG | 1 |
| Freeman, S; Shulman, LP | 1 |
| Bifulco, G; Di Carlo, C; Formisano, C; Gargano, V; Massaro, M; Nappi, C | 1 |
| Weisberg, E | 1 |
| Briones-Landa, CH; Bustillos-Alamilla, E; Hernández-Ruiz, MA; Zepeda-Zaragoza, J | 1 |
| Foldemo, A; Josefsson, A; Lindberg, M; Wiréhn, AB | 1 |
| Cheetham, TC; Connell, FA; Cooper, WO; Davis, D; Graham, DJ; Ouellet-Hellstrom, R; Quesenberry, CP; Sidney, S; Sorel, M | 1 |
| Kallio, S; Piltonen, T; Puurunen, J; Ruokonen, A; Tapanainen, JS; Vaskivuo, T | 1 |
| Mansour, D; Shapiro, S; Szarewski, A | 1 |
| Bateson, D; Briggs, P; McNamee, K | 1 |
| Bizior-Frymus, D; Dyja, R; Jonderko, K; Kamińska, M; Kasicka-Jonderko, A; Skałba, P | 1 |
| Cogque-Hernandez, G; Garcia-Latorre, EA; Hernandez-Giron, X; Hernandez-Juarez, J; Isordia-Salas, I; Julián-Nacer, R; Majluf-Cruz, A; Moran-Perez, JF; Moreno-Hernandez, M; Palafox-Gomez, R; Rodriguez-Escobedo, MA | 1 |
| Angsuwathana, S; Chaovisitsaree, S; Jaisamrarn, U; Nerapusee, O | 1 |
| Abe, J; Fukuda, A; Hane, Y; Hasegawa, S; Hatahira, H; Hirade, K; Kinosada, Y; Matsui, T; Motooka, Y; Naganuma, M; Nakamura, M; Sasaoka, S; Takahashi, Y | 1 |
| Burchardt, NA; Eliassen, AH; Fortner, RT; Kaaks, R; Rosner, B; Shafrir, AL; Tamimi, RM; Tworoger, SS | 1 |
18 review(s) available for norgestrel and desogestrel
| Article | Year |
|---|---|
Comparative review of third-generation progestins.
Topics: Contraceptives, Oral; Desogestrel; Female; Humans; Norgestrel; Norpregnenes | 1992 |
The new era in oral contraception: pills containing gestodene, norgestimate, and desogestrel.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Norgestrel; Norpregnenes; Pregnancy; Progesterone Congeners | 1992 |
Characteristics of the new progestogens in combination oral contraceptives.
Topics: Blood Coagulation; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Desogestrel; Humans; Lipid Metabolism; Norgestrel; Norpregnenes; Progesterone Congeners | 1991 |
Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids.
Topics: Animals; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes | 1990 |
Gastrointestinal metabolism of contraceptive steroids.
Topics: Aged; Biological Availability; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Gastric Mucosa; Humans; Intestinal Mucosa; Male; Middle Aged; Norgestrel; Norpregnenes; Sulfates | 1990 |
Clinical aspects of three new progestogens: desogestrel, gestodene, and norgestimate.
Topics: Carbohydrate Metabolism; Desogestrel; Drug Evaluation; Female; Humans; Lipid Metabolism; Menstrual Cycle; Norgestrel; Norpregnenes; Pregnancy; Progesterone Congeners; Proteins | 1989 |
Metabolic aspects of the new low-dose oral contraceptives.
Topics: Carbohydrate Metabolism; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Norgestrel; Norpregnenes; Proteins | 1989 |
[What does the micropill bring?].
Topics: Blood Coagulation; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Lipid Metabolism; Norgestrel; Norpregnenes; Ovary; Progesterone Congeners; Risk | 1986 |
[New progestational hormones].
Topics: Contraceptives, Oral, Hormonal; Desogestrel; Female; Humans; Nandrolone; Norgestrel; Norpregnenes; Progesterone Congeners | 1988 |
Progestins in preventive hormone therapy. Including pharmacology of the new progestins, desogestrel, norgestimate, and gestodene: are there advantages?
Topics: Breast Neoplasms; Cardiovascular Diseases; Desogestrel; Endometrium; Estrogen Replacement Therapy; Female; Humans; Norgestrel; Norpregnenes; Osteoporosis, Postmenopausal; Progesterone Congeners; Risk Factors; Structure-Activity Relationship | 1994 |
Evaluation of a new generation of oral contraceptives. The Advisory Board for the New Progestins.
Topics: Androgens; Blood Coagulation; Blood Glucose; Contraceptives, Oral; Desogestrel; Female; Humans; Insulin; Lipid Metabolism; Norgestrel; Norpregnenes; Progesterone Congeners | 1993 |
Pharmacokinetics of the new progestogens and influence of gestodene and desogestrel on ethinylestradiol metabolism.
Topics: Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Norgestrel; Norpregnenes; Progesterone Congeners | 1997 |
New hormonal contraceptives: a comprehensive review of the literature.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Desogestrel; Drug Combinations; Drug Interactions; Estradiol; Ethinyl Estradiol; Ethisterone; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Norgestrel; Oximes | 2003 |
Enhancing oral contraceptive success: the potential of new formulations.
Topics: Chemistry, Pharmaceutical; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Norgestrel | 2004 |
The role of combined oral contraceptives in the management of acne and seborrhea.
Topics: Acne Vulgaris; Contraceptives, Oral; Contraceptives, Oral, Combined; Dermatitis, Seborrheic; Desogestrel; Ethinyl Estradiol; Female; Humans; Norgestrel; Norpregnenes; Safety; Treatment Outcome | 2004 |
Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences.
Topics: Affect; Contraception; Contraception Behavior; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Desogestrel; Drug Administration Schedule; Drug Combinations; Drug Implants; Ethisterone; Female; Humans; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Norgestrel; Oximes; Patient Education as Topic; Progesterone Congeners; Risk Factors; United States; Weight Gain; Women's Health | 2004 |
Hormonal contraception: recent advances.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethisterone; Female; Humans; Levonorgestrel; Male; Medroxyprogesterone Acetate; Norgestrel; Oximes; Venous Thrombosis; Women's Health | 2006 |
Considerations for the use of progestin-only contraceptives.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Counseling; Desogestrel; Drug Prescriptions; Family Planning Services; Female; Health Promotion; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Patient Education as Topic; Patient Selection; Pregnancy, Unplanned; Progesterone Congeners; Risk Factors; United States | 2010 |
49 trial(s) available for norgestrel and desogestrel
| Article | Year |
|---|---|
A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
Topics: Adult; Apolipoproteins; Blood Glucose; Ceruloplasmin; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Pancuronium; Progesterone Congeners; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 1992 |
A comparative study on the effects of a monophasic pill containing desogestrel plus 20 micrograms ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors.
Topics: Adult; Analysis of Variance; Blood Coagulation Factors; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinopeptide A; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Norpregnenes; Progesterone Congeners; Random Allocation | 1991 |
The clinical and biochemical effects of two combination oral contraceptive agents.
Topics: Adolescent; Adult; Age Factors; Apolipoproteins A; Apolipoproteins B; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Lipoproteins; Norgestrel; Norpregnenes; Progesterone Congeners; Triglycerides | 1991 |
Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
Topics: Androgen Antagonists; Apolipoproteins; Cyproterone; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Lipid Metabolism; Lipids; Lipoproteins; Medroxyprogesterone; Menopause; Middle Aged; Norgestrel; Norpregnenes | 1991 |
The effect of follicular growth and luteal function of "missing the pill". A comparison between a monophasic and a triphasic combined oral contraceptive.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Corpus Luteum; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Follicular Phase; Humans; Levonorgestrel; Luteal Phase; Norgestrel; Norpregnenes; Ovarian Follicle; Ovary; Time Factors | 1991 |
[Side effects of oral contraceptives in the first treatment cycle].
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Fertilization in Vitro; Humans; Norgestrel; Norpregnenes; Pilot Projects; Prospective Studies; Retrospective Studies | 1991 |
Serum lipids in Chinese patients using oral contraceptive pills.
Topics: Adult; China; Cholesterol; Congresses as Topic; Contraceptives, Oral; Desogestrel; Family Planning Services; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes | 1990 |
Low-dose oral contraceptives lower plasma levels of apolipoprotein E.
Topics: Adolescent; Adult; Apolipoproteins A; Apolipoproteins B; Apolipoproteins E; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Norgestrel; Norpregnenes; Triglycerides | 1990 |
Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Levonorgestrel; Luteinizing Hormone; Male; Norgestrel; Norpregnenes; Pituitary Gland; Prolactin; Sex Hormone-Binding Globulin; Testosterone | 1986 |
Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
Topics: Adolescent; Adult; Carbohydrate Metabolism; China; Cholesterol; Desogestrel; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Lipid Metabolism; Lipoproteins; Longitudinal Studies; Norgestrel; Norpregnenes; Prospective Studies; Singapore; Triglycerides | 1989 |
Effects of three types of combined O.C. pills on blood coagulation, fibrinolysis and platelet function.
Topics: Adenosine Diphosphate; Adult; Blood Coagulation; Blood Platelets; Blood Pressure; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Fibrinolysis; Hematocrit; Humans; Menstrual Cycle; Norgestrel; Norpregnenes; Platelet Aggregation; Progesterone Congeners | 1989 |
Effects of seven low-dose combined contraceptives on vitamin B6 status.
Topics: Adolescent; Adult; Aspartate Aminotransferases; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Desogestrel; Erythrocytes; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Progestins; Pyridoxal Phosphate; Pyridoxine; Time Factors | 1989 |
Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone Congeners; Stereoisomerism | 1987 |
A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levels.
Topics: Adult; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Random Allocation; Testosterone | 1985 |
A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins.
Topics: Adult; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, VLDL; Norgestrel; Norpregnenes; Phospholipids; Random Allocation; Triglycerides | 1985 |
Carbohydrate metabolism in women who used oral contraceptives containing levonorgestrel or desogestrel: a 6-month prospective study.
Topics: Adult; Blood Glucose; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Erythrocytes; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Norgestrel; Norpregnenes; Prospective Studies; Pyruvates; Pyruvic Acid; Random Allocation; Receptor, Insulin | 1986 |
Comparative effects of monophasic desogestrel plus ethinyloestradiol and triphasic levonorgestrel plus ethinyloestradiol on lipid metabolism.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Phospholipids; Triglycerides | 1986 |
Effects of three low-dose oral contraceptive formulations on lipid metabolism.
Topics: Adolescent; Adult; Arteriosclerosis; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Prospective Studies; Random Allocation | 1987 |
Changes in lipoprotein composition in women receiving two low-dose oral contraceptives containing ethinylestradiol and gonane progestins.
Topics: Adult; Apolipoproteins; Cholesterol, HDL; Contraceptives, Oral, Hormonal; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins; Norgestrel; Norpregnenes; Prospective Studies | 1988 |
Comparative metabolic effects of oral contraceptive preparations containing different progestagens. Effects of desogestrel + ethinylestradiol on the haemostatic balance.
Topics: Adult; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cholesterol; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinolysis; Glucose Tolerance Test; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone Congeners; Random Allocation; Time Factors; Triglycerides | 1985 |
Effects of two progestins with different androgenic properties on hepatic endothelial lipase and high density lipoprotein2.
Topics: Androgens; Apolipoprotein A-I; Apolipoproteins A; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Endothelium; Esterification; Female; Heparin; Humans; Levonorgestrel; Lipase; Lipoproteins; Lipoproteins, HDL; Liver; Middle Aged; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin; Testosterone | 1985 |
Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Phospholipids; Triglycerides | 1985 |
Effects of desogestrel, levonorgestrel and lynestrenol on serum sex hormone binding globulin, cortisol binding globulin, ceruloplasmin and HDL-cholesterol.
Topics: Adolescent; Adult; Carrier Proteins; Ceruloplasmin; Cholesterol, HDL; Clinical Trials as Topic; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Lynestrenol; Norgestrel; Norpregnenes; Random Allocation; Sex Hormone-Binding Globulin | 1985 |
Progestagens and high-density lipoproteins.
Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Norgestrel; Norpregnenes | 1984 |
Effects of desogestrel and levonorgestrel in low-dose oestrogen oral contraceptives on serum lipoproteins.
Topics: Adult; Cholesterol; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Norgestrel; Norpregnenes | 1982 |
Comparative effects of the oral contraceptive combinations 0.150 mg desogestrel + 0.030 mg ethinyloestradiol and 0.150 mg levonorgestrel + 0.030 mg ethinyloestradiol on lipid and lipoprotein metabolism in healthy female volunteers.
Topics: Adolescent; Adult; Body Weight; Cholesterol Esters; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Fatty Acids; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Norgestrel; Norpregnenes; Phosphatidylcholines; Triglycerides | 1982 |
Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination.
Topics: Adolescent; Adult; Blood Proteins; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Denmark; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Fatty Acids; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Norway; Pregnancy; Sex Hormone-Binding Globulin; Sweden; Transcortin | 1982 |
Effects of levonorgestrel and desogestrel in low-dose oral contraceptive combinations on serum lipids, apolipoproteins A-I and B and glycosylated proteins.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Cholesterol, HDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glycoproteins; Humans; Levonorgestrel; Lipids; Lipoproteins, HDL; Norgestrel; Norpregnenes; Progesterone Congeners; Stereoisomerism; Triglycerides | 1984 |
Ovarian function during low-dose oral contraceptive use.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Norgestrel; Ovarian Cysts; Ovary; Patient Compliance; Progesterone; Prospective Studies; Smoking; Ultrasonography | 1995 |
Effects of two low-dose oral contraceptives on erythrocyte superoxide dismutase, catalase and glutathione peroxidase activities.
Topics: Adult; Catalase; Contraceptives, Oral, Hormonal; Desogestrel; Erythrocytes; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glutathione Peroxidase; Humans; Lipid Peroxidation; Malondialdehyde; Norgestrel; Superoxide Dismutase | 1993 |
Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
Topics: Adult; Androgens; Blood Pressure; Body Weight; Carrier Proteins; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Dihydrotestosterone; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hydroxyprogesterones; Norgestrel; Norpregnenes; Progesterone Congeners; Prospective Studies; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone | 1995 |
Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Topics: Adolescent; Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Lipids; Norgestrel; Norpregnenes; Progesterone Congeners | 1995 |
Changes in androgens during treatment with four low-dose contraceptives.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgens; Androstenedione; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Dihydrotestosterone; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Hydroxyprogesterones; Luteal Phase; Norgestrel; Norpregnenes; Pancuronium; Progestins; Sex Hormone-Binding Globulin; Testosterone; Transcortin | 1996 |
The effects of monophasic and triphasic oral contraceptives on ovarian function and endometrial thickness.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cross-Sectional Studies; Desogestrel; Drug Combinations; Endometrium; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Middle Aged; Norgestrel; Norpregnenes; Ovary; Progesterone | 1997 |
An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group.
Topics: Blood Coagulation; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Peptide Fragments; Prothrombin; Thrombin; Venous Thrombosis | 1999 |
Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations.
Topics: Adolescent; Adult; Breast; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Hormones; Humans; Menstrual Cycle; Middle Aged; Nausea; Norgestrel; Pregnancy; Statistics, Nonparametric; Uterine Hemorrhage | 1999 |
Effect of hormone replacement therapy on lipids in perimenopausal and early postmenopausal women.
Topics: Adult; Apolipoprotein A-I; Cholesterol, HDL; Cholesterol, LDL; Climacteric; Desogestrel; Double-Blind Method; Estradiol; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Linear Models; Lipoprotein(a); Lipoproteins; Middle Aged; Norgestrel; Postmenopause; Treatment Outcome | 2001 |
The effect of hormone replacement therapy on serum homocysteine levels in perimenopausal women: a randomized controlled trial.
Topics: Adult; Climacteric; Desogestrel; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Homocysteine; Humans; Middle Aged; Norgestrel; Progesterone Congeners | 2001 |
Influence of low-dose oral contraception on peripheral blood lymphocyte subsets at particular phases of the hormonal cycle.
Topics: Adult; Antigens, CD; B-Lymphocytes; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Killer Cells, Natural; Lymphocyte Subsets; Lymphocytes, Null; Menstrual Cycle; Norgestrel; Prospective Studies; Reference Values | 2002 |
Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Administration Schedule; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Ovarian Follicle; Treatment Outcome; Ultrasonography | 2004 |
Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive.
Topics: Administration, Intravaginal; Adolescent; Adult; Analysis of Variance; Body Mass Index; Contraceptive Devices, Female; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Norgestrel; Weight Gain | 2005 |
[Safety evaluation of a transdermal contraceptive system with an oral contraceptive].
Topics: Administration, Cutaneous; Administration, Oral; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Women's Health | 2005 |
Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use.
Topics: Adolescent; Adult; Body Weight; Contraception; Contraceptives, Oral; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Patient Satisfaction; Time Factors; Weight Gain | 2007 |
Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis.
Topics: Administration, Cutaneous; Adolescent; Adult; Choice Behavior; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Endometriosis; Ethinyl Estradiol; Female; Humans; Menstruation Disturbances; Norgestrel; Pain Measurement; Patient Satisfaction; Uterine Diseases; Young Adult | 2010 |
Oral contraceptives elevate core temperature and heart rate during exercise in the heat.
Topics: Adult; Body Temperature; Body Temperature Regulation; Contraceptives, Oral; Desogestrel; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Exercise; Female; Heart Rate; Hot Temperature; Humans; Levonorgestrel; Luteal Phase; Mestranol; Norethindrone; Norgestrel; Skin Temperature | 1997 |
Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study.
Topics: Absorptiometry, Photon; Amino Acids; Analysis of Variance; Bone and Bones; Bone Density; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Norgestrel; Oximes; Prospective Studies | 2010 |
[Combined hormonal contraception in cycles artificially extended].
Topics: Administration, Cutaneous; Adolescent; Adult; Androstenes; Breast Diseases; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Dysmenorrhea; Ethinyl Estradiol; Female; Headache; Humans; Menstrual Cycle; Norgestrel; Patient Acceptance of Health Care; Prospective Studies; Time Factors; Uterine Hemorrhage; Young Adult | 2010 |
Antimüllerian hormone levels decrease in women using combined contraception independently of administration route.
Topics: Administration, Cutaneous; Adult; Anti-Mullerian Hormone; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Follicle Stimulating Hormone, Human; Humans; Norgestrel; Ovarian Follicle; Oximes; Pituitary Gland; Prospective Studies; Young Adult | 2013 |
A comparison of multiphasic oral contraceptives containing norgestimate or desogestrel in acne treatment: a randomized trial.
Topics: Acne Vulgaris; Adult; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Norgestrel; Treatment Outcome; Young Adult | 2014 |
67 other study(ies) available for norgestrel and desogestrel
| Article | Year |
|---|---|
Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles.
Topics: Adult; Anovulation; Desogestrel; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Inhibins; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Norgestrel; Norpregnenes; Ovarian Diseases; Ovulation; Progesterone; Progestins | 1991 |
Effects of low-dose oral contraceptives on female whole saliva.
Topics: Adult; Buffers; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Male; Menstrual Cycle; Menstruation; Norgestrel; Norpregnenes; Ovulation; Progesterone Congeners; Saliva; Salivary Proteins and Peptides | 1991 |
Clinical results with subcutaneous implants containing 3-keto desogestrel.
Topics: Binding, Competitive; Contraceptives, Oral, Combined; Desogestrel; Dihydrotestosterone; Drug Implants; Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norgestrel; Norpregnenes; Ovulation; Progesterone; Progesterone Congeners; Sex Hormone-Binding Globulin; Testosterone | 1990 |
Relative binding affinity of norgestimate and other progestins for human sex hormone-binding globulin.
Topics: Binding, Competitive; Desogestrel; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progestins; Sex Hormone-Binding Globulin; Testosterone | 1990 |
Potency and pharmacokinetics of gestagens.
Topics: Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes | 1990 |
Effects of three combined oral contraceptive preparations containing desogestrel plus ethinyl estradiol on lipid metabolism in comparison with two levonorgestrel preparations.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Progesterone Congeners | 1990 |
Hemostasis profile in women taking low-dose oral contraceptives.
Topics: Adult; Blood Coagulation Factors; Blood Platelets; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Fibrinolysis; Hemostasis; Humans; Norgestrel; Norpregnenes; Progesterone Congeners; Reference Values; Serum Globulins | 1990 |
The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Ethynodiol Diacetate; Female; Humans; Insulin; Levonorgestrel; Lipid Metabolism; Middle Aged; Norethindrone; Norgestrel; Norpregnenes; Progesterone Congeners; Triglycerides | 1990 |
Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
Topics: Administration, Oral; Adult; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin | 1990 |
Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolism.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Menstrual Cycle; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin | 1990 |
Comparison of the lipoprotein and hemostatic changes after a triphasic and a monophasic low dose oral contraceptive in premenopausal middle-aged women.
Topics: Adult; Antithrombin III; Cholesterol; Cholesterol, HDL; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Hemostasis; Humans; Lipoproteins; Lipoproteins, LDL; Norgestrel; Norpregnenes; Protein C; Triglycerides | 1990 |
Altered growth hormone secretion during oral contraception.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Growth Hormone; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Pituitary Gland, Anterior; Progesterone Congeners | 1990 |
Binding of oral contraceptive progestogens to serum proteins and cytoplasmic receptor.
Topics: Animals; Binding, Competitive; Blood Proteins; Contraceptives, Oral, Hormonal; Cytoplasm; Desogestrel; Female; Humans; Kinetics; Levonorgestrel; Male; Norgestrel; Norpregnenes; Pregnancy; Progesterone; Progesterone Congeners; Progestins; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Sex Hormone-Binding Globulin; Transcortin; Uterus | 1990 |
Binding of levonorgestrel, norethisterone and desogestrel to human sex hormone binding globulin and influence on free testosterone levels.
Topics: Binding, Competitive; Desogestrel; Female; Humans; In Vitro Techniques; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Pregnancy; Pregnancy Trimester, Third; Sex Hormone-Binding Globulin; Testosterone | 1989 |
Pituitary-ovarian activity when switching from various monophasic pills to a triphasic pill.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstruation; Norethindrone; Norgestrel; Norpregnenes; Ovarian Follicle; Ovary; Pituitary Gland; Progesterone; Progestins | 1989 |
A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic serum parameters: II. Effects upon thyroid function, gastrin, STH, and glucose tolerance.
Topics: Adult; Blood Glucose; Contraceptives, Oral; Desogestrel; Drug Evaluation; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Gastrins; Growth Hormone; Humans; Norgestrel; Norpregnenes; Random Allocation; Thyroid Gland; Thyroid Hormones | 1985 |
Endometrial morphology during a normophasic and a triphasic regimen: a comparison.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes | 1986 |
Oral contraceptives and blood coagulation.
Topics: Age Factors; Antithrombin III; Blood Coagulation; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Factor VII; Factor X; Female; Fibrinolysis; Humans; Norgestrel; Norpregnenes; Platelet Aggregation; Prothrombin; Thromboembolism | 1986 |
Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin; Testosterone | 1987 |
Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives.
Topics: Adult; Amenorrhea; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Life Style; Menstrual Cycle; Norgestrel; Norpregnenes | 1987 |
Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
Topics: Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Lipoproteins; Norethindrone; Norgestrel; Norpregnenes; Population Surveillance; Progesterone Congeners; Prospective Studies; Risk | 1987 |
Coagulation effects of oral contraception.
Topics: Blood Coagulation; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinolysis; Humans; Levonorgestrel; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes; Platelet Aggregation; Risk Factors; Thromboembolism; Thrombosis | 1987 |
New progestogens in oral contraceptives.
Topics: Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Progesterone Congeners | 1987 |
Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Cholesterol, HDL; Contraceptives, Oral; Desogestrel; Epoprostenol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Norgestrel; Norpregnenes; Thromboxane A2; Thromboxane B2 | 1987 |
Trace elements during 2 years' oral contraception with low-estrogen preparations.
Topics: Calcium; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Copper; Desogestrel; Ethinyl Estradiol; Female; Humans; Iron; Levonorgestrel; Norgestrel; Norpregnenes; Trace Elements; Zinc | 1988 |
Progestagen-dependent effect on some plasma proteins during oral contraception.
Topics: Blood Proteins; Ceruloplasmin; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Pregnancy Proteins; Progesterone Congeners; Sex Hormone-Binding Globulin; Transcortin | 1988 |
Comparative effects of combined oral contraceptives containing desogestrel or levonorgestrel on serum lipids, lipoproteins and sex hormone binding globulin in healthy women.
Topics: Adult; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Lipoproteins; Norgestrel; Norpregnenes; Prospective Studies; Random Allocation; Sex Hormone-Binding Globulin; Triglycerides | 1988 |
Salivary and plasma free testosterone and androstenedione levels in women using oral contraceptives containing desogestrel or levonorgestrel.
Topics: Adolescent; Adult; Androstenedione; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Female; Fertility; Humans; Levonorgestrel; Middle Aged; Norgestrel; Norpregnenes; Saliva; Sex Hormone-Binding Globulin; Testosterone | 1988 |
Bioactive LH in women with polycystic ovaries and the effect of gonadotrophin suppression.
Topics: Adolescent; Adult; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Menstrual Cycle; Norgestrel; Norpregnenes; Polycystic Ovary Syndrome; Progesterone; Progesterone Congeners | 1988 |
Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives.
Topics: Cell Line; Cytosol; Desogestrel; Dihydrotestosterone; In Vitro Techniques; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Pregnenediones; Receptors, Androgen; Receptors, Progesterone; Tritium | 1988 |
[Dependence of morphologic changes in portio, cervix and endometrium on dosage or potency of synthetic gestagens].
Topics: Cell Transformation, Neoplastic; Cervix Uteri; Desogestrel; Dose-Response Relationship, Drug; Endometrium; Female; Humans; Lynestrenol; Norgestrel; Norpregnenes; Progesterone Congeners; Risk; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Uterine Neoplasms; Vagina; Vaginal Neoplasms | 1985 |
The effects of two gonane progestins alone and in combination with ethinyl estradiol on serum lipoproteins.
Topics: Adult; Castration; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Norgestrel; Norpregnenes | 1985 |
Time- and dose-dependent alterations of basal and LH-RH-stimulated LH-release during treatment with various hormonal contraceptives.
Topics: Animals; Chlormadinone Acetate; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Levonorgestrel; Luteinizing Hormone; Norethindrone; Norgestrel; Norpregnenes; Rats | 1984 |
Anti-estrogenic effects of contraceptive progestins on the dynamics of gonadotropin release.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Drug Interactions; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Longitudinal Studies; Luteinizing Hormone; Lynestrenol; Norgestrel; Norpregnenes; Pituitary Gland | 1982 |
Effects of two oral contraceptive combinations, 0.125 mg desogestrel + 0.050 mg ethinylestradiol and 0.125 mg levonorgestrel + 0.050 mg ethinylestradiol on the adrenal function of healthy female volunteers.
Topics: 17-Hydroxycorticosteroids; Adrenal Cortex; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Levonorgestrel; Metyrapone; Norgestrel; Norpregnenes; Progestins; Random Allocation | 1982 |
Endocrinological studies with desogestrel.
Topics: Administration, Oral; Animals; Castration; Contraceptives, Oral, Combined; Decidua; Desogestrel; Endometrium; Estrogen Antagonists; Female; Levonorgestrel; Mice; Norethindrone; Norgestrel; Norpregnenes; Ovulation; Pregnancy; Progesterone Congeners; Rabbits; Rats; Species Specificity | 1983 |
Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Norpregnenes; Progesterone; Prolactin; Random Allocation; Serum Globulins; Sex Hormone-Binding Globulin; Transcortin | 1983 |
Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel.
Topics: Adult; Biological Availability; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Radioimmunoassay; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone; Transcortin | 1984 |
Changes in serum apo-lipoprotein AI and sex-hormone-binding globulin levels after treatment with two different progestins administered alone and in combination with ethinyl estradiol.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins; Arteriosclerosis; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Middle Aged; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin | 1984 |
Changes in relative fatty acid composition of serum lecithin and cholesterol ester after treatment with two gonane progestins administered alone and in combination with ethinyl estradiol.
Topics: Adult; Castration; Cholesterol Esters; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Fatty Acids; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Norpregnenes; Phosphatidylcholines; Progesterone Congeners; Stereoisomerism; Uterine Cervical Neoplasms | 1984 |
Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives.
Topics: Adolescent; Adult; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombin III; Carrier Proteins; Complement System Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy Proteins; Protease Inhibitors; Serum Albumin; Sex Hormone-Binding Globulin; Steroids; Transcortin | 1993 |
[Clinical-physiological characteristics and hormone therapy of patients with typical form of climacteric syndrome].
Topics: Climacteric; Desogestrel; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Norethindrone; Norgestrel; Syndrome; Time Factors | 1994 |
Metabolism of the oral contraceptive steroids ethynylestradiol, norgestimate and 3-ketodesogestrel by a human endometrial cancer cell line (HEC-1A) and endometrial tissue in vitro.
Topics: Chromatography, High Pressure Liquid; Contraceptives, Oral, Hormonal; Desogestrel; Endometrial Neoplasms; Endometrium; Estradiol; Estrone; Ethinyl Estradiol; Female; Humans; Kinetics; Norgestrel; Tumor Cells, Cultured | 1993 |
European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Topics: Adult; Aging; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Data Collection; Desogestrel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estradiol Congeners; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progesterone Congeners; Risk Factors; Smoking; Surveys and Questionnaires | 1995 |
Safety of combined oral contraceptive pills.
Topics: Adult; Blood Coagulation Factors; Contraceptives, Oral, Combined; Cross-Sectional Studies; Desogestrel; Female; Fibrinolysis; Humans; Lipids; Middle Aged; Norgestrel; Norpregnenes; Progesterone Congeners; Thromboembolism | 1996 |
Laboratory criteria for menopause in women using oral contraceptives.
Topics: Adult; Aged; Contraceptives, Oral; Desogestrel; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Norgestrel; Pilot Projects; Prospective Studies; Time Factors | 1996 |
The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.
Topics: Adolescent; Adult; Bias; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Odds Ratio; Progesterone Congeners; Risk Factors; Thromboembolism | 1996 |
The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
Topics: Adolescent; Adult; Body Mass Index; Case-Control Studies; Causality; Contraceptives, Oral; Denmark; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Levonorgestrel; Migraine Disorders; Multivariate Analysis; Norgestrel; Norpregnenes; Risk Factors; Smoking; Socioeconomic Factors; Thromboembolism | 1997 |
Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives.
Topics: Adolescent; Adult; Age Factors; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Incidence; Levonorgestrel; Myocardial Infarction; Norethindrone; Norgestrel; Risk Factors; Thrombophlebitis; United States | 1997 |
Risk of oral contraceptives and recency of market introduction.
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Odds Ratio; Time Factors | 1997 |
Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives.
Topics: Adolescent; Adult; Aged; Contraceptives, Oral, Combined; Desogestrel; Factor V; Female; Hemostasis; Heterozygote; Humans; Levonorgestrel; Male; Middle Aged; Norgestrel; Norpregnenes; Protein C; Thrombin; Thrombophlebitis | 1997 |
[Changes in the concentration of individual proteins in women using current peroral contraceptives].
Topics: Adolescent; Adult; Blood Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Norgestrel | 1999 |
Recurrent use of newer oral contraceptives and the risk of venous thromboembolism.
Topics: Adult; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Logistic Models; Norgestrel; Norpregnenes; Risk Factors; Venous Thrombosis | 2000 |
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
Topics: Biomarkers; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Predictive Value of Tests; Risk Factors; Sex Hormone-Binding Globulin; Venous Thrombosis | 2002 |
New drugs 2003, part II.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Approval; Drug Combinations; Drug Therapy; Epoprostenol; Estradiol; Ethisterone; Filgrastim; Fondaparinux; Fulvestrant; Granulocyte Colony-Stimulating Factor; Humans; Norgestrel; Oximes; Polyethylene Glycols; Polysaccharides; Recombinant Proteins; Triptorelin Pamoate; United States; Vinyl Compounds | 2003 |
Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Databases, Factual; Desogestrel; Female; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Odds Ratio; Risk Factors; Thromboembolism | 2006 |
Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch.
Topics: Administration, Cutaneous; Adolescent; Adult; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Desogestrel; Female; Humans; Intracranial Thrombosis; Levonorgestrel; Norgestrel; Risk; Sinus Thrombosis, Intracranial | 2006 |
Clinical inquiries. What hormonal contraception is most effective for obese women?
Topics: Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Evidence-Based Medicine; Female; Humans; Medroxyprogesterone Acetate; Norgestrel; Obesity; Pregnancy; Pregnancy Rate; Risk Assessment | 2007 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: a nationwide population-based study with age-specific analyses.
Topics: Adolescent; Adult; Age Distribution; Antidepressive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Drug Utilization; Female; Humans; Levonorgestrel; Logistic Models; Lynestrenol; Medroxyprogesterone; Norgestrel; Odds Ratio; Oximes; Population Surveillance; Practice Patterns, Physicians'; Registries; Sweden | 2012 |
Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.
Topics: Adolescent; Adult; Androstenes; Arteries; California; Child; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Hospitalization; Humans; Incidence; Middle Aged; Myocardial Infarction; Norgestrel; Proportional Hazards Models; Risk Factors; Stroke; Tennessee; Thromboembolism; Time Factors; Venous Thromboembolism; Washington; Young Adult | 2013 |
Another flawed database study.
Topics: Androstenes; Contraceptive Agents, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Norgestrel; Venous Thromboembolism | 2013 |
Newer non-oral hormonal contraception.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Drug Implants; Drug Monitoring; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Safety; Treatment Outcome | 2013 |
Impact of combined oral contraceptives containing ethinylestradiol on the liver microsomal metabolism.
Topics: Acetamides; Adult; Androstenes; Breath Tests; Carbon Radioisotopes; Case-Control Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Cytochrome P-450 CYP1A2; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Menstrual Cycle; Norgestrel; Norpregnenes; Young Adult | 2013 |
Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: a prospective study.
Topics: Adiponectin; Adult; C-Peptide; C-Reactive Protein; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Insulin-Like Growth Factor I; Leptin; Lipid Metabolism; Liver Function Tests; Longitudinal Studies; Mexico; Norgestrel; Oximes; Thyroid Function Tests; Transdermal Patch; Weight Gain | 2014 |
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Androstenes; Child; Contraceptives, Oral, Combined; Databases, Factual; Desogestrel; Drug-Related Side Effects and Adverse Reactions; Estrogens; Ethinyl Estradiol; Female; Humans; Japan; Levonorgestrel; Male; Middle Aged; Norethindrone; Norgestrel; Odds Ratio; Progestins; Thromboembolism; Young Adult | 2017 |
Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses' Health Study II: a prospective cohort study.
Topics: Breast Neoplasms; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Nurses; Progestins; Prospective Studies | 2022 |